BioVie Inc (BIVI)
3.165
-0.24
(-7.18%)
USD |
NASDAQ |
Nov 14, 16:00
3.16
0.00 (0.00%)
After-Hours: 18:20
BioVie Enterprise Value: 28.84M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 28.84M |
| November 12, 2024 | 28.01M |
| November 11, 2024 | 23.05M |
| November 08, 2024 | 19.75M |
| November 07, 2024 | 18.37M |
| November 06, 2024 | 15.06M |
| November 05, 2024 | 15.27M |
| November 04, 2024 | 16.44M |
| November 01, 2024 | 20.02M |
| October 31, 2024 | 19.61M |
| October 30, 2024 | 20.99M |
| October 29, 2024 | 17.13M |
| October 28, 2024 | 21.40M |
| October 25, 2024 | 21.26M |
| October 24, 2024 | 19.20M |
| October 23, 2024 | 17.27M |
| October 22, 2024 | 28.15M |
| October 21, 2024 | 6.408M |
| October 18, 2024 | 0.6175M |
| October 17, 2024 | -9.202M |
| October 16, 2024 | -9.122M |
| October 15, 2024 | -9.361M |
| October 14, 2024 | -9.042M |
| October 11, 2024 | -8.723M |
| October 10, 2024 | -8.802M |
| Date | Value |
|---|---|
| October 09, 2024 | -8.483M |
| October 08, 2024 | -7.844M |
| October 07, 2024 | -8.563M |
| October 04, 2024 | -8.643M |
| October 03, 2024 | -8.723M |
| October 02, 2024 | -8.643M |
| October 01, 2024 | -8.962M |
| September 30, 2024 | -8.563M |
| September 27, 2024 | -8.626M |
| September 26, 2024 | -9.34M |
| September 25, 2024 | -8.626M |
| September 24, 2024 | -10.67M |
| September 23, 2024 | -0.4161M |
| September 20, 2024 | -0.6693M |
| September 19, 2024 | -0.2261M |
| September 18, 2024 | 0.217M |
| September 17, 2024 | 0.5336M |
| September 16, 2024 | 1.673M |
| September 13, 2024 | 1.863M |
| September 12, 2024 | 1.926M |
| September 11, 2024 | 0.1537M |
| September 10, 2024 | -0.7959M |
| September 09, 2024 | -2.062M |
| September 06, 2024 | -2.379M |
| September 05, 2024 | -1.492M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-10.67M
Minimum
Sep 24 2024
611.76M
Maximum
Feb 03 2021
115.49M
Average
95.40M
Median
Jan 10 2022
Enterprise Value Benchmarks
| Catalyst Pharmaceuticals Inc | 2.277B |
| MediciNova Inc | 53.26M |
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.941M |
| Total Expenses (Quarterly) | 4.790M |
| EPS Diluted (Quarterly) | -0.30 |
| Earnings Yield | -233.8% |